f Novel Anti-tumor Bio-drugs and Therapeutic Strategies in Cancer Management: From Bench to Translational Research

References

1. HuangS. YinY. LiJ. ShiM. BianH. ZhaoL. Evaluation of treatments with radiotherapy alone and radiotherapy plus chemo-immunotherapy in patients with primary liver cancer based on blood biomarkers.Curr. Med. Chem.202431406586659510.2174/0929867331666230822121246 37608661
   [Google Scholar]
2. AlnukhaliM. AltabbakhO. FarooqiA.A. PollackA. DaunertS. DeoS. TaoW. Activation of stimulator of interferon genes (STING): Promising strategy to overcome immune resistance in prostate cancer.Curr. Med. Chem.202431406556657110.2174/0109298673273303231208071403 38347787
   [Google Scholar]
3. PengZ. DingY. ZhangP. LvX. LiZ. ZhouX. HuangS. Artificial intelligence application for anti-tumor drug synergy prediction.Curr. Med. Chem.202431406572658510.2174/0109298673290777240301071513
   [Google Scholar]
4. UllahA. UllahS. WaqasM. KhanM. RehmanN.U. KhalidA. JanA. AzizS. NaeemM. HalimS. KhanA. Al-HarrasiA. Novel natural inhibitors for glioblastoma by targeting epidermal growth factor receptor and phosphoinositide 3-kinase.Curr. Med. Chem.202431406596661310.2174/0109298673293279240404080046 38616761
   [Google Scholar]